CGT Release
Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck
Pharma's Almanac
PAO-10-26-PA-07Oct 12, 2026
Pathfinder
Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?
Nice Insight
PAO-26-PF-28Oct 9, 2026
Nonviral Delivery
Can Nonviral Delivery Change the Economics of Gene Therapy?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-02Oct 5, 2026
Pathfinder
Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?
Nice Insight
PAO-26-PF-27Oct 2, 2026
Viral Vectors
Gene Therapy Manufacturing After the Capacity Boom
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-01Oct 1, 2026
New Technology
What are the key bottlenecks preventing rapid adoption of novel technologies?
Pharma's Almanac
PAO-09-26-RT-01Sep 30, 2026
Biocatalysis
When Does Biocatalysis Create the Better Manufacturing Process?
Yusho Kato
Kaneka
PAO-09-26-CL-07Sep 28, 2026
Pathfinder
Micronization vs. Nanomilling vs. Amorphous Solid Dispersions: Which Is Better for Poorly Soluble Drugs?
Nice Insight
PAO-26-PF-26Sep 25, 2026
DS + DP Integration
Integrating Drug Substance and Drug Product to Reduce Risk Across Development
Dörthe Ackenhausen
IDT Biologika
PAO-09-26-CL-02Sep 24, 2026
Oncolytic Viruses
Turning Oncolytic Viruses into Manufacturable Cancer Therapies
Luisa Amoedo Otero
Recipharm Advanced Bio
PAO-09-26-CL-04Sep 22, 2026
Drug Shortage
What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-16Sep 22, 2026
DSP
Why More Product Upstream Creates New Pressure Downstream
Pharma's Almanac
PAO-09-26-PA-15Sep 21, 2026
Enzymatic Synthesis
Transforming Enzymatic Processes into Commercial-Scale Manufacturing
Kohei Mori
Kaneka
PAO-09-26-CL-03Sep 18, 2026
Pathfinder
Platform Development vs. Molecule-Specific Process Development: Which Strategy Is Better for Biologics?
Nice Insight
PAO-26-PF-25Sep 18, 2026
Oncolytic Viruses
Manufacturing Oncolytic Viruses: Where Complexity Demands Experience
Mathias Kahl
IDT Biologika
PAO-09-26-CL-01Sep 17, 2026
CCS and CMC
Packaging Returns to the Center of CMC Strategy
Pharma's Almanac
PAO-09-26-PA-10Sep 14, 2026
iPSCs
For iPSC Therapies, Manufacturing Consistency May Mean Preserving Function
Pharma's Almanac
PAO-09-26-PA-09Sep 11, 2026
Pathfinder
Enzymatic Synthesis vs. Fermentation for Biomanufacturing: Which Production Strategy Is Better?
Nice Insight
PAO-26-PF-24Sep 11, 2026
Partnership
Samsung Biologics Signs USD 262 Million Manufacturing Agreement with European Pharmaceutical Company
Samsung Biologics
PR-09-26-02Sep 10, 2026
Single-Use
The Changing Economics of Single-Use Biomanufacturing
Pharma's Almanac
PAO-09-26-PA-08Sep 10, 2026